Intravitreous Recombinant Tissue Plasminogen Activator and Gas to Treat Submacular Hemorrhage in Age-Related Macular Degeneration

Intravitreous Recombinant Tissue Plasminogen Activator and Gas to Treat Submacular Hemorrhage in Age-Related Macular Degeneration

We evaluated the safety and efficacy of intravitreous recombinant tissue plasminogen activator (rTPA) and gas for the treatment of submacular hemorrhage in age-related macular degeneration (ARMD). From January 2000 to April 2002, we enrolled 15 patients with submacular hemorrhage secondary to ARMD....

Full description

Bibliographic Details
Main Authors:	San-Chang Tsai, Jane-Ming Lin, Hsin-Yi Chen
Format:	Article
Language:	English
Published:	Wiley 2003-12-01
Series:	Kaohsiung Journal of Medical Sciences
Subjects:	recombinant tissue plasminogen activator submacular hemorrhage age-related macular degeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S1607551X09705145

Similar Items

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
by: Ramin Nourinia, et al.
Published: (2010-01-01)

Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
by: Remzi Avcı, et al.
Published: (2021-01-01)

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
by: Karagiannis D, et al.
Published: (2017-11-01)

Management of a Submacular Hemorrhage Secondary to Age-Related Macular Degeneration: A Comparison of Three Treatment Modalities
by: Seongyong Jeong, et al.
Published: (2020-09-01)

Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series
by: Direk Patikulsila, et al.
Published: (2022-10-01)

Macular hole and submacular hemorrhage secondary to retinal arterial macroaneurysm – successfully treated with a novel surgical technique
by: Nourinia, Ramin, et al.
Published: (2020-08-01)

Three-dimensional heads-up system assisted pars plana vitrectomy and subretinal recombinant tissue plasminogen activator injection for submacular hemorrhage
by: Xinyu Zhao, et al.
Published: (2023-03-01)

Pneumatic displacement for management of traumatic macular hole with submacular hemorrhage
by: Maithili Mishra, et al.
Published: (2020-01-01)

Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration
by: Mustafa Gok, et al.
Published: (2017-01-01)

Delayed, spontaneous conversion of type 2 closure to type 1 closure following surgery for traumatic macular hole associated with submacular hemorrhage
by: Pukhraj Rishi, et al.
Published: (2012-01-01)

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial
by: Timothy L. Jackson, et al.
Published: (2022-01-01)

Development and spontaneous closure of a secondary macular hole associated with submacular hemorrhage due to polypoidal choroidal vasculopathy: a case report
by: Minami Chino, et al.
Published: (2020-03-01)

A Case of Traumatic Submacular Hemorrhage Treated with tPA and Pneumatic Displacement
by: Lorenzo Motta, et al.
Published: (2023-11-01)

Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series
by: Debdulal Chakraborty, et al.
Published: (2022-03-01)

Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration
by: Sachin Jain, et al.
Published: (2013-01-01)

Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis
by: Xuejun He, et al.
Published: (2023-01-01)

The Mechanism of Gas in Submacular Hemorrhage [Letter]
by: Özyol E
Published: (2021-10-01)

Long-Term Favorable Visual Outcomes in Patients with Large Submacular Hemorrhage
by: Iyer PG, et al.
Published: (2021-03-01)

Outcomes in the Treatment of Subretinal Macular Hemorrhage Secondary to Age-Related Macular Degeneration: A Systematic Review
by: Filippo Confalonieri, et al.
Published: (2024-01-01)

Progress in treatment of submacular hemorrhage due to polypoid choroidal vasculopathy
by: Shuang Zhang, et al.
Published: (2019-06-01)

Intravitreal gas for submacular haemorrhage
by: Mahesh Gopalakrishnan, et al.
Published: (2003-01-01)

Subretinal tissue plasminogen-assisted vitrectomy for posttraumatic full-thickness macular hole with submacular hemorrhage
by: Pradeep Kumar, et al.
Published: (2018-01-01)

ANALYSIS OF CLINICAL CASES АНТИ-VEGF TREATMENT OF MASSIVE SUBRETINAL HEMORRHAGES COMPLICATING WET AGE-RELATED MACULAR DEGENERATION
by: E. V. Kozina, et al.
Published: (2017-01-01)

Management of iatrogenic globe perforation during peribulbar anesthesia with submacular hemorrhage
by: Abdulaziz Al-Shehri, et al.
Published: (2020-01-01)

Traumatic submacular hemorrhage: available treatment options and synthesis of the literature
by: Giamberto Casini, et al.
Published: (2019-12-01)

The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
by: A. D. Ovchinnikova, et al.
Published: (2021-01-01)

Submacular surgery
by: Saxena Sandeep, et al.
Published: (1997-01-01)

Intravitreal r-tPA Injection and Pneumatic Displacement for Submacular Retinal Hemorrhage: A Case Series
by: Filippo Confalonieri, et al.
Published: (2022-08-01)

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy
by: Yorihisa Kitagawa, et al.
Published: (2022-04-01)

Displacement of submacular hemorrhage with intravitreal tissue plasminogen activator following 27 gauge transvitreal fine needle aspiration biopsy for choroidal melanoma
by: Ramsudha Narala, et al.
Published: (2022-03-01)

Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages
by: Subhendu Kumar Boral, et al.
Published: (2023-01-01)

Submacular hemorrhage: A study amongst Indian eyes
by: Ekta Rishi, et al.
Published: (2012-01-01)

Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods
by: Carsten Grohmann, et al.
Published: (2020-07-01)

Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series
by: Somnath Chakraborty, et al.
Published: (2022-11-01)

Macular Hemorrhage Due to Age-Related Macular Degeneration or Retinal Arterial Macroaneurysm: Predictive Factors of Surgical Outcome
by: Mitta Pierre, et al.
Published: (2021-12-01)

A RARE CASE OF SPONTANEOUS SUPRACHOROIDAL HEMORRHAGE IN PATIENT WITH ARTERIAL HYPERTENSION AND WET AGE-RELATED MACULAR DEGENERATION
by: A. A. Kazaryan, et al.
Published: (2015-10-01)

Submacular cysticercosis in two cases: Course and outcome
by: Ramanuj Samanta, et al.
Published: (2020-01-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Prevalence and genetic analyses of selected age-related macular degeneration-related polymorphisms and their responses to intravitreal ranibizumab
by: Mohamad, Nur Afiqah
Published: (2018)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
by: Ren Aoki, et al.
Published: (2021-10-01)